Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

The implantation of bioprosthetic heart valves (BHVs) is increasingly becoming the treatment
of choice in patients requiring heart valve replacement surgery. Unlike mechanical heart …

Significant coronary artery disease (CAD) is a frequent finding in patients with severe aortic
stenosis undergoing transcatheter aortic valve implantation (TAVI), and the management of …

Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Objectives The aim of this study was to evaluate clinical characteristics, mechanisms of
failure, and outcomes of transcatheter aortic valve replacement (TAVR) explantation …

731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

Background Valve reintervention after transcatheter aortic valve replacement (TAVR) failure
has not been studied in detail. Objectives The authors sought to determine outcomes of …

Objectives The aim of this study was to evaluate the risk of coronary obstruction due to sinus
sequestration in redo transcatheter aortic valve replacement (TAVR) using post-TAVR …

Background Surgical aortic valve replacement and transcatheter aortic valve replacement
(TAVR) are now both used to treat aortic stenosis in patients in whom life expectancy may …

Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger
and lower surgical risk patients. Given the longer life expectancy of these patients, the …